Torbiel endometrialna i jej zmiany w trakcie ciąży - przegląd piśmiennictwa

Endometriosis in the population of pregnant patients

Endometriosis is associated with the presence of glands and endometrial stroma outside the uterine cavity. The disease affects about 10% of women of reproductive age, 50% of patients diagnosed for infertility, and 70% diagnosed for chronic abdominal pain [1, 2]. The highest prevalence of endometriosis occurs in patients between 25 and 35 years of age [3]; this is also the age of peak procreation in Europe. Endometriosis affects the quality of life of patients and their procreative plans. The most frequent location of lesions is the ovary (67% of patients with laparoscopically confirmed endometriosis) [4]. Ovarian endometriosis most often takes the form of a cyst – endometrioma (so-called “chocolate cyst”). Given the average age of procreation in Europe, the age range of patients with the highest prevalence of endometriosis, and the tendency to relapse after treatment, the coexistence of pregnancy and endometriosis is often observed in clinical practice [5].

Pregnancy in patients with endometriosis

Pain, infertility or subfertility are typical symptoms of endometriosis. Pain in patients suffering from endometriosis during pregnancy usually disappears or alleviates, and endometrial lesions decrease in size [6]. Factors influencing changes in endometrial lesions are the period of gestation (the chance of regression of the lesion increases with the progression of pregnancy) and the size of the lesion (greater tendency to complete regression in the case of diameter < 20 mm). The literature also describes histological features of endometriosis foci increasing susceptibility to regression under the influence of gestagens [6]. However, patients who become pregnant have an increased risk of certain obstetric complications compared to pregnant patients without diagnosed endometriosis. Such complications include miscarriage – OR (odds ratio) = 1.76 (95% CI: 1.44–2.15), ectopic pregnancy – OR = 2.70 (95% CI: 1.09–6.72), pre-eclampsia (OR = 1.18, 95% CI: 1.01–1.39), gestational diabetes (RR (relative risk) = 1.26, 95% CI: 1.03–1.55), gestational cholestasis (OR = 4.87, 95% CI: 1.85–12.83), placenta previa (OR = 3.31, 95% CI: 2.37–4.63), antepartum haemorrhage (OR = 1.69, 95% CI: 1.38–2.07), and antepartum hospital admissions (OR = 3.18, 95% CI: 2.60–3.87). There is also a higher risk of neonatal complications such as preterm premature rupture of membranes (OR = 2.33, 95% CI: 1.39–3.90), stillbirth (OR = 1.29, 95% CI: 1.10–1.52), preterm birth (OR = 1.70, 95% CI: 1.40–2.06), small for gestational age (< 10 percentile) (OR = 1.28, 95% CI: 1.11–1.49), and admission to a neonatal intensive care unit (OR = 1.39, 95% CI: 1.08–1.78) [7–11]. The literature also presents cases of surgical complications of visceral endometriosis such as intestinal perforation, appendicitis, rapture of endometriomas and fallopian tubes, or spontaneous pneumothorax [6].

Endometrioma during pregnancy and decidualization process

The occurrence of endometrioma in the population of pregnant patients is estimated at approx. 0.5% [12]. Population studies indicate that ultrasound examination of the ovaries with a vaginal probe in the 1st trimester of pregnancy during 1st trimester prenatal examinations (11–13+6 weeks of gestation) allows visualization in approx. 11% of patients with adnexal tumours (taking into account only complex and simple cysts with a diameter greater than 5 cm) [13]. In the cohort presented in a study among patients who underwent enucleation of an ovarian cyst during pregnancy due to pain, suspected cancer, or the patient’s request, histopathological diagnosis of endometrioma was made in 24.2% of cases and was the second most common diagnosis after dermoid cysts (36.4%) [13]. Ultrasound diagnosis of an endometrial cyst is rather straightforward: unilocular cyst with low-level homogenic internal echoes (“ground glass”), clear demarcation from ovarian parenchyma, increased through-transmission of acoustic beam, usually with no solid areas and papillary projections (Figure 1). Such an image of endometrioma is not universal, but it affects up to 80% of tumours [14].
The goal of endometrioma treatment outside pregnancy is to reduce pain and prevent complications related to rupture and torsion of the ovary, as well as to treat infertility while maintaining ovarian reserve. An important element is also the exclusion of cancer. Endometriosis is associated with a small increased risk of ovarian cancer (standardized incidence ratio (SIR) 1.76, 95% CI: 1.47–2.08). This relationship is mainly related to endometrioid (SIR = 3.12, 95% CI: 2.15–4.38) and clear cell (SIR = 5.17, 95% CI: 3.20–7.89) cancer [15, 16]. Patients should be informed about the increased risk of ovarian cancer. The increase in life-time absolute risk of ovarian cancer for patients with endometriosis is small and amounts to 1.8% (in the general population the risk is 1.31%) [17]. A definite histological diagnosis can only be made after surgical removal of cysts. Surgical treatment, despite the advantages of direct evaluation of the tissue collected, is limited due to potential postoperative complications [18, 19].
Medical treatment is an alternative to surgical treatment. Commonly used therapies are progestogens alone, estrogen-progestin contraceptive pills or GnRH agonists. This treatment is aimed at decidualizing endometriotic foci (secretory transformation), followed by ectopic endometrial atrophy. This process reduces bleeding from ectopic endometrial lesions and reduces the local inflammatory reaction, and thus the patient’s pain. Despite the lack of access to the abdominal cavity and the histological examination of the lesion, such a procedure avoids the risk associated with the surgery and its potential complications. Pregnancy is a physiological condition associated with elevated progesterone levels. It is initially produced by the corpus luteum. Later, between the 7th and 10th week of pregnancy, the placenta becomes its primary production site. At the beginning of pregnancy, its serum concentration ranges from 8 to 48 ng/ml, while its concentration in the serum is between 100 and 200 ng/ml during full-term pregnancy [20]. On the one hand, high progesterone concentrations in pregnancy result in the reduction of the patient’s pain, but may lead to the initiation of the process of endometrioma decidualization, i.e. secretory transformation. The process itself has no implications for the patient’s health but is a diagnostic challenge for the doctor. Knowledge about this process is essential because it can imitate ovarian cancer in ultrasound. The process of endometrioma growth in pregnancy concerns about 20% of cases. Tumour growth is not always associated with decidualization, and ultrasound enlargement may also occur as a result of abscess formation or rupture [12]. In half of the cases the size of the endometrioma is reduced, and in 28% it remains unchanged [12].

Ultrasound features of the decidualization of endometriomas

Decidualized endometrioma has no pathognomonic ultrasound features. In the initial stage of decidualization, an increase in the echogenicity of the contents of the inside of the cyst can be observed (Figure 2); with time, the most disturbing symptom for an ultrasound examiner is papillary projection into the lumen of the cyst (Figure 3). In the literature, we can find mainly case series. On this basis, researchers are trying to establish common diagnostic features that help differentiate endometrioma decidualization from ovarian cancer. However, differentiation is not easy, especially in the case of de novo diagnosis in patients whose ovarian lesions were not diagnosed in the first trimester of pregnancy. Most of the tumours subject to decidualization present in the ultrasound the morphology of unilocular cysts with solid components (52%), and in 39% they present the multilocular form with solid components. The number of papillary outgrowths in the lumen of the cyst varies significantly between tumours; however, most often these are 3 papillary projections (33% of decidualized endometriomas), and they have a maximum diameter between 6 mm and 79 mm and a height of 3–33 mm. Almost all the projections show colour or power Doppler signals (94%); this signal is usually well expressed (colour score 3 – 72%) (Figures 4 A, B). A feature that seems to be characteristic is the smooth surface of papillary projections (82% of decidualized endometriomas) (21) (Figure 3). Papillary projections are clearly visible in macroscopic preparations of excised lesions (Figure 5). Commonly used in the medical community, ultrasound diagnostic models of ovarian lesions such as Simple Rules (International Ovarian Tumour Analysis – IOTA) or mixed models also using other clinical data (including Ca125 concentration) such as ADNEX (IOTA) or RMI (risk malignancy index) are not standardized to the population of pregnant patients, which may lead to a high false positive ratio.
The diagnostics of endometrioma decidualization is a challenge for the ultrasound examiner. In one study, 18 cysts diagnosed postoperatively as endometrioma decidualization were subjected to an ultrasound evaluation of the lesion. In 56% of the cysts, the ultrasound examiner was not able to assess the malignancy potential, and only in 17% was the examiner sure that the lesion was benign. Borderline tumour was suspected in 44% of cases [21]. In such a situation, the most valuable diagnostic clue seems to be a typical image of endometrioma in an ultrasound examination before pregnancy or in the first trimester, before the decidualization process begins.

Serum markers in the process of differentiating malignant changes from decidualized endometriomas

In the process of differentiation of decidualized endometrioma and ovarian cancer, tumour markers are limited of use. Before pregnancy, in patients suffering from endometriosis, the concentration of the Ca125 marker is usually already slightly elevated or within the upper limits of the normal range, and is characterized by a greater population spread (median – 44 U/ml, 75th percentile – 85 U/ml) and significantly higher than in the case of other benign cysts of the ovary (median – 15 U/ml, 75th percentile – 24 U/ml) [14]. Serum Ca125 levels are elevated in most ovarian cancer cases. Meta-analysis shows an overall sensitivity and specificity (Ca125 > 35 U/ml) of 78% [22]. However, the sensitivity of the test depends on the stage of the ovarian cancer and the type of cancer (it is lower in mucous and clear cell carcinomas) [23, 24]. The use of a pregnancy test at the cut-off point for the premenopausal population may result in a significant reduction in specificity and an increase in the false positive ratio. Ca125 may be useful in differentiating ovarian cancer from a benign lesion after 15 weeks of gestation until the moment of delivery; at this time, significantly elevated levels (> 1000 U/ml) usually suggest a proliferative disease, but concentrations of lower order of magnitude (100–150 U/ml) are not rare at this stage of pregnancy and do not provide additional diagnostic information [25].
Concentrations of other cancer markers that may be helpful in the diagnosis of ovarian cancer in pregnancy, i.e. carcinoembryonic antigen (CEA), -fetoprotein (AFP), and human chorionic gonadotropins (hCG), are usually increased during pregnancy and are characterized by high variability during pregnancy; additionally, their concentrations may be affected by maternal or foetal complications [25]. In contrast, the median HE4 concentration during pregnancy is lower compared to non-pregnant patients in reproductive age [26, 27]. All cancer markers have limited usefulness in differentiating between endometrioma decidualization and ovarian cancer.

Conclusions

Endometrioma decidualization is not a common process among patients with diagnosed endometrioma, but it is a process that every clinician should know about, given the benign nature and the ultrasound image imitating ovarian cancer. In our opinion, ovaries should be examined ultrasonographically for pathological changes in the first trimester in pregnancy. The presentation of a typical endometrial cyst image supports the diagnostic process of decidualization in the second trimester of pregnancy. Due to the small number of cases described in the literature, there are currently no standards (expectant management/surgical procedure) in the case of patients with endometrial decidualization image; each patient requires an individualised approach. Further research is needed to search for ultrasound and biochemical markers of the decidualization process.

Acknowledgments

Project financed under the program of the Minister of Science and Higher Education called “Regional Initiative of Excellence” in the years 2019-2022, project no. 024/RID/2018/19, amount of financing 11 999 000.00 zł.

Conflict of interest

The authors declare no conflict of interest.

References